Theriva Biologics, Inc. Annual Operating Lease, Payments in USD from 2019 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Theriva Biologics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2021.
  • Theriva Biologics, Inc. Operating Lease, Payments for the quarter ending September 30, 2022 was $142K, a 77.5% increase year-over-year.
  • Theriva Biologics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2022 was $480K, a 51.4% increase year-over-year.
  • Theriva Biologics, Inc. annual Operating Lease, Payments for 2021 was $321K, a 3.88% increase from 2020.
  • Theriva Biologics, Inc. annual Operating Lease, Payments for 2020 was $309K, a 3% increase from 2019.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $321K +$12K +3.88% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-16
2020 $309K +$9K +3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-16
2019 $300K Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
* An asterisk sign (*) next to the value indicates that the value is likely invalid.